Mutational dynamics between primary and relapse neuroblastomas
Nature Genetics2015Vol. 47(8), pp. 872–877
Citations Over TimeTop 1% of 2015 papers
Alexander Schramm, Johannes Köster, Yassen Assenov, Kristina Althoff, Martin Peifer, E Mahlow, Andrea Odersky, Daniela Beißer, Corinna Ernst, Anton G. Henssen, Harald Stephan, Christopher Schröder, Lukas C. Heukamp, Anne Engesser, Yvonne Kahlert, Jessica Theißen, Barbara Hero, Frederik Roels, Janine Altmüller, Peter Nürnberg, Kathy Astrahantseff, Christian Johannes Gloeckner, Katleen De Preter, Christoph Plass, Sangkyun Lee, Holger N. Lode, Kai-Oliver Henrich, Moritz Gartlgruber, Frank Speleman, Peter Schmezer, Frank Westermann, Sven Rahmann, Matthias Fischer, Angelika Eggert, Johannes H. Schulte
Related Papers
- → Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy(2024)279 cited
- → Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth(2023)31 cited
- → Kras and Hras—what is the difference?(2008)11 cited
- → Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy(2023)5 cited
- → Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer.(2020)